Kits Eyecare (TSE:KITS)
TSX:KITS
Want to see TSE:KITS full AI Analyst Report?
KITS Stock Chart & Stats
C$15.19
-C$0.04(-0.48%)
At close: 4:00 PM EST
C$15.19
-C$0.04(-0.48%)
Day’s Range― - ―
52-Week RangeC$10.61 - C$22.56
Previous CloseN/A
Volume7.67K
Average Volume (3M)53.64K
Market Cap
C$498.59M
Enterprise ValueC$435.98M
Total Cash (Recent Filing)C$21.98M
Total Debt (Recent Filing)C$5.63M
Price to Earnings (P/E)136.8
Beta1.30
Next Earnings
Aug 06, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.11
Shares Outstanding33,986,810
10 Day Avg. Volume77,427
30 Day Avg. Volume53,639
Financial Highlights & Ratios
PEG Ratio-103.69
Price to Book (P/B)9.43
Price to Sales (P/S)2.90
P/FCF Ratio51.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$21.46Price Target Upside41.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.26
Revenue Forecast (FY)C$244.32M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthKits has delivered multi-year top-line expansion (2022–2025 plus positive TTM growth). Persistent revenue momentum in a DTC eyecare model supports scale economies, better absorption of fixed costs, and durable demand that underpins longer-term margin improvement and investment capacity.
Improved Gross Margin & ProfitabilityA meaningful uplift to gross margin (~36.5%) and a return to TTM net income indicate improving unit economics and pricing/fulfillment effectiveness. These structural improvements make profitability more sustainable and enable reinvestment in customer acquisition and product development.
Conservative Balance Sheet / Low LeverageVery low leverage and a marked reduction in debt provide financial flexibility for growth initiatives, cushion against demand shocks, and optionality for opportunistic M&A or capital allocation without pressuring cash flow or increasing insolvency risk.
Bears Say
Thin Operating & Net MarginsMargins remain thin despite revenue gains, leaving earnings highly sensitive to cost inflation, marketing spend, and pricing pressure. Small adverse swings in CAC, input or fulfillment costs could materially erode profitability and slow progress toward durable high-return economics.
Sharp Free Cash Flow DeclineA near-50% drop in FCF year-over-year signals weaker cash conversion or working-capital volatility. Persistent FCF weakness would constrain reinvestment, limit margin-boosting initiatives, and reduce resilience to operational setbacks over the medium term.
Negative EPS Growth TrendMaterial negative EPS growth despite revenue expansion points to earnings volatility from margin compression, one-offs, or dilution. Inconsistent EPS trajectory complicates forecasting and undermines confidence in steady per-share value creation over the coming quarters.
Kits Eyecare News
KITS FAQ
What was Kits Eyecare’s price range in the past 12 months?
Kits Eyecare lowest stock price was C$10.61 and its highest was C$22.56 in the past 12 months.
What is Kits Eyecare’s market cap?
Kits Eyecare’s market cap is C$498.59M.
When is Kits Eyecare’s upcoming earnings report date?
Kits Eyecare’s upcoming earnings report date is Aug 06, 2026 which is in 53 days.
How were Kits Eyecare’s earnings last quarter?
Kits Eyecare released its earnings results on May 06, 2026. The company reported C$0.052 earnings per share for the quarter, missing the consensus estimate of C$0.053 by -C$0.001.
Is Kits Eyecare overvalued?
According to Wall Street analysts Kits Eyecare’s price is currently Undervalued.
Does Kits Eyecare pay dividends?
Kits Eyecare does not currently pay dividends.
What is Kits Eyecare’s EPS estimate?
Kits Eyecare’s EPS estimate is 0.04.
How many shares outstanding does Kits Eyecare have?
Kits Eyecare has 33,986,810 shares outstanding.
What happened to Kits Eyecare’s price movement after its last earnings report?
Kits Eyecare reported an EPS of C$0.052 in its last earnings report, missing expectations of C$0.053. Following the earnings report the stock price went down -13.366%.
Which hedge fund is a major shareholder of Kits Eyecare?
Currently, no hedge funds are holding shares in TSE:KITS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kits Eyecare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$21.46 (41.27% Upside)
C$21.46 (41.27% Upside)
Blogger Sentiment
Neutral
TSE:KITS Sentiment 100%
Sector Average 66%
Sector Average 66%
Insider Transactions
Sold Shares
Worth C$1.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.5%
Last 30 Days ▲ 5.8%
Last 30 Days ▲ 5.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.06%
12-Months-Change
Fundamentals
Return on Equity
5.50%
Trailing 12-Months
Asset Growth
6.29%
Trailing 12-Months
Company Description
Kits Eyecare
Kits Eyecare Ltd. operates an online vision care platform that serves customers throughout the United States and Canada. The company produces its own range of KITS-branded products, encompassing progressive and contact lenses, as well as spectacles and frames. Additionally, it acts as a distributor for eyewear items from numerous other brands. Its operations are facilitated through a collection of e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Established in 2018, Kits Eyecare Ltd. maintains its primary business location in Vancouver, Canada.
KITS Stock 12 Month Forecast
Average Price Target
C$21.46
▲(41.27% Upside)
Technical Analysis
Alimentation Couche-Tard Inc
―
Leon's Furniture
―
Canadian Tire
―
Emerge Commerce Ltd
―
Pet Valu Holdings Ltd.
―
Options Prices
Currently, No data available
---